Tag: pharmaceutical companies

Liability Concerns for Physicians, Providers, Hospital and Reproductive Clinics following the Alabama Supreme Court Ruling in LePage v. Center for Reproductive Medicine – the “Sanctity of Human Life” Opinion Much has been written in social media about the recent decision by the Supreme Court of Alabama in LePage v. Center for Reproductive Medicine. While the […]

You have been watching the news, waiting, or in some cases desperately waiting for the government to “re-open the economy.”  There are steps you can and should take to prepare your company to open safe legally. Human Resources:  The world of HR changed rapidly during the pandemic.  The federal and state governments passed new laws […]

It is a story often heard by health care lawyers.  Clients come into the office regarding a dispute with their partners, their investors, a shareholder, or a party interested in a venture.  They tell the lawyer how they have an agreement (shareholder, operating or a partnership agreement).  The client feels like it is all “black […]

Health care is “under innovation.” No matter how health care is reformed, new and old arrangements will remain highly regulated, with new technology and collaborations moving faster than the law can adapt. Outdated regulations, some not amended in over two decades, may seem no longer relevant, but regulators won’t hesitate to use them. Innovators in health […]

New Jersey prescribers receiving almost anything of value from a pharmaceutical manufacturer, must ensure that such compensation complies with a new state regulation that took effect January 16, 2018.  The rule, Limitations on and Obligations Associated with Acceptance of Compensation from Pharmaceutical Manufacturers by Prescribers, was adopted as one of the last acts of the […]